Association of a G994 → T missense mutation in the plasma platelet- activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese

Circulation

Volumn 98, Issue 18, 1998, Pages 1881-1885

  Ichihara, Sahoko ^a   Yamada, Yoshiji ^b   Yokota, Mitsuhiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Cardiomyopathy; Genes; Platelets

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PHOSPHOLIPASE A;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GENETIC SUSCEPTIBILITY; HEART DILATATION; HEART LEFT VENTRICLE MASS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; BLOOD; CONGESTIVE CARDIOMYOPATHY; ECHOGRAPHY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REFERENCE VALUE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGED; BASE SEQUENCE; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHOLIPASES A; REFERENCE VALUES;

EID: 0032480640     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.18.1881     Document Type: Article

References (36)

1. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB III, Cody RJ, Fishman MC, Cox N, Kong A, Wooley CF, Seidman JG, Seidman CE. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet. 1994;7:546-551.
2. Durand JB, Bachinski LL, Bieling LC, Czernuszewics GZ, Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, Brugada R, Daiger S, Gregoritch JM, Anderson JL, Quinones M, Towbin JA, Roberts R. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 1995;92:3387-3389.
3. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 1996;97:528-532.
4. Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Filaschi A, Camerini F, Giacca M, Mestroni L. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet. 1995;57:846-852.
5. Bowles KR, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R, Towbin JA. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 1996; 98:1355-1360.
6. Bolhuis PA, Hensels GW, Hulsebos TJM, Baas F, Barth PG. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet. 1991;48:481-485.
7. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu X-M, Chamberlain JS, McCabe ERB, Swift M. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854-1865.
8. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921-925.
9. Michels VV, Moll PP, Miller FA, Tajik J, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77-82.
10. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-163.
11. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Bergh RV, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
12. Li Y, Huang T, Carlson EJ, Melov S, Ursell PC, Olson JL, Nobel LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11:376-381.
13. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Dionne L, Lu N, Huang S, Matzuk MM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A. 1996;93:9782-9787.
14. Zimmerman GA, Prescott SM, McIntyre TM. Platelet-activating factor: a fluid-phase and cell-associated mediator of inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press; 1992:149-176.
15. Kenzora JL, Perez JE, Bergmann SR, Lange LG. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. J Clin Invest. 1984; 74:1193-1203.
16. Alloatti G, Montrucchio G, Camussi G. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. J Pharmacol Exp Ther. 1994;269:766-771.
17. Patel KD, Zimmerman GA, Prescott SM, McIntyre TM. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem. 1992;267:15168-15175.
18. Smiley PL, Stremler KE, Prescott SM, Zimmerman GA, McIntyre TM. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem. 1991; 266:11104-11110.
19. Stafforini DM, Prescott SM, McIntyre TM. Human platelet-activating factor acetylhydrolase: purification and properties. J Biol Chem. 1987; 262:4223-4230.
20. Stremler KE, Stafforini DM, Prescott SM, McIntyre TM. Human platelet-activating factor acetylhydrolase: oxidatively fragmented phospholipids as substrates. J Biol Chem. 1991;266:11095-11103.
21. Yamada Y, Stafforini DM, Imaizumi T, Zimmerman GA, McIntyre TM, Prescott SM. Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes. Proc Natl Acad Sci U S A. 1994;91:10320-10324.
22. Stafforini DM, Sotoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T, Takamatsu S, Zimmerman GA, McIntyre TM, Gray PW. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest. 1996;97:2784-2791.
23. Teichholtz LE, Cohen MV, Sonnenblick EH, Gorlin R. Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med. 1974;291:1220-1226.
24. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation. 1977;55:613-618.
25. Brugada R, Kelsey W, Lechin M, Zhao G, Yu Q-T, Zoghbi W, Quinones M, Elstein E, Omran A, Rakowski H, Wigle D, Liew C-C, Sole M, Roberts R, Marian AJ. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med. 1997;45:542-551.
26. Kimball TR, Daniels SR, Meyer RA, Schwartz DC, Kaplan S. Left ventricular mass in childhood dilated cardiomyopathy: a possible predictor for selection of patients for cardiac transplantation. Am Heart J. 1991;122:126-131.
27. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1989;13:311-315.
28. Hess ML, Okabe E, Ash P, Kontos HA. Free radical mediation of the effects of acidosis on calcium transport by cardiac sarcoplasmic reticulum in whole heart homogenates. Cardiovasc Res. 1984;18:149-157.
29. Olson RD, Boerth RC, Gerber JG, Nies AS. Mechanism of Adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci. 1981;29: 1393-1401.
30. Dorshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 1983;43:460-472.
31. Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, Li T. Combination therapy with probucol prevents Adriamycin-induced cardiomyopathy. J Mol Cell Cardiol. 1995;27:1055-1063.
32. Richter C, Park J-W, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A. 1988;85:6465-6467.
33. Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Trong HL, Cousens LS, Zimmerman GA, Yamada Y, McIntyre TM, Prescott SM, Gray PW. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995;374:549-552.
34. Sugimoto T, Tsuchimochi H, McGregor CGA, Mutoh H, Shimizu T, Kurachi Y. Molecular cloning and characterization of the platelet-activating factor receptor gene in the human heart. Biochem Biophys Res Commun. 1992;189:617-624.
35. 279→Phe) is a genetic risk factor for stroke. Stroke. 1997;28:2417-2420.
36. 994→T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism. 1998;47:177-181.